-
Fernandes 'proud' to match Premier League assists record
-
Germany set to miss 2030 climate goal: experts
-
G7 finance chiefs meet to seek common stance on unstable ground
-
Hantavirus-hit cruise ship docks in Rotterdam at voyage end
-
Philippines swears in senators for VP Duterte's impeachment trial
-
Iran's World Cup football team leaves for Turkey: media
-
Hantavirus-hit cruise ship steams towards Rotterdam at voyage end
-
Japan arrests Americans over stunt at baby monkey Punch's zoo
-
Trump says 'clock ticking' for Iran as peace negotiations stall
-
Hong Kong court hears closing arguments in Tiananmen activists' trial
-
World Cup duo Ghana, Cape Verde not among AFCON top seeds
-
African players in Europe: Daring Semenyo wins final for City
-
Kenya's new poaching problem: smuggling Giant Harvester Ants
-
WHO kicks off annual assembly amid hantavirus, Ebola crises
-
S. Korean blockbuster 'Hope' underscores growing film ambition
-
Train driver charged after deadly Bangkok bus collision
-
Angry Chinese table tennis fans demand apology for flag gaffe
-
India's lifeline ferry across strategic archipelago
-
Encroaching world threatens India's last 'uncontacted' tribe
-
India's strategic $9 bn megaport plan for pristine island
-
In Tierra del Fuego, a hunt for the rodent carrier of hantavirus
-
Mitchell leads Cavs past top-seeded Detroit into NBA East finals
-
China's April consumption, factory output growth slowest in years
-
Asian stocks sink, oil rises on US-Iran deadlock
-
Cleveland Cavaliers eliminate top-seeded Detroit from NBA playoffs
-
Who could be the 2026 World Cup's breakout star?
-
Humble PGA champ Rai celebrates English, Indian, Kenyan heritage
-
Hantavirus-hit cruise ship nears end of voyage, to dock in Rotterdam
-
He said, she said, AI said: Wall Street sex scandal rivets and confounds
-
UN General Assembly to take up climate change 'obligations' resolution
-
Four takeaways from Musk vs OpenAI trial
-
Jury to decide fate of Musk's blockbuster suit against OpenAI
-
Frustrated McIlroy drops F-bomb in exchange with PGA heckler
-
Defending champion Palou storms to Indy 500 pole
-
Messi shines as Inter Miami finally win at new stadium
-
Shai Gilgeous-Alexander wins second straight NBA MVP award
-
White House mass prayer event seeks to reclaim US Christian roots
-
International dive group joins Maldives search for missing Italians
-
'Staggering' Iran toll drives up global executions: Amnesty
-
June 29 Marijuana Rescheduling Hearing Faces Constitutional Issues Before It Even Begins
-
Aliko Dangote: African Energy Person of the Year 2026
-
Agronomics Limited Announces Net Asset Value Calculation as at 31 March 2026
-
Santa Barbara Schools Sexual Assault Complaint by Veen Firm
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 18
-
Rai wins first major at PGA with back-nine birdie blitz
-
Woad bags second LPGA title at Queen City Championship
-
Lebanon says Israeli strikes kill 7 as Hezbollah condemns talks
-
Revived La Rochelle trounce Top 14 leaders Toulouse
-
PSG beaten by Paris FC in Ligue 1 as Lille qualify for Champions League
-
Griezmann apologetic on emotional Atletico Madrid farewell
US Supreme Court preserves access to abortion pill
The US Supreme Court on Friday temporarily preserved access to a widely used abortion pill, freezing rulings by lower courts that would have banned or severely restricted availability of the drug.
Two conservative justices disagreed with the decision in the most significant abortion case to reach the nine-member court since it overturned the constitutional right to the procedure 10 months ago.
Without commenting on the merits of the case, the decision by the nation's highest court means that mifepristone, which accounts for more than half of the abortions in the United States, will remain available while the case plays out in an appeals court.
The Justice Department of President Joe Biden had filed an emergency appeal asking the Supreme Court to block the lower court rulings that would have banned or limited use of mifepristone.
The case stems from a ruling by a US District Court judge in Texas, in a lawsuit brought by anti-abortion groups, that would have banned mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000.
An appeals court blocked a ban on the pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court decision effectively freezes the lower court rulings pending the an appellate court hearing of the appeal from the Justice Department and mifepristone manufacturer Danco Laboratories.
Reacting to the Supreme Court move, Biden said the lower court decisions "would have undermined FDA's medical judgment and put women's health at risk."
"As a result of the Supreme Court's stay, mifepristone remains available and approved for safe and effective use while we continue this fight in the courts," Biden said in a statement. "I will continue to fight politically-driven attacks on women's health."
- 'Deeply misguided' -
Since the Supreme Court overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century, 13 states have banned abortion and it has been severely restricted in others.
Opposition to the legal assault on the abortion pill is being spearheaded by the Justice Department, which argued that the initial ruling by the federal judge in Texas was based on a "deeply misguided assessment" of the pill's safety.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure -- or ban it outright.
L.Harper--AMWN